Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 647.08B, Johnson & Johnson(JNJ) trades at $256.22. The stock has a price-to-earnings ratio of 30.53 and currently yields dividends of 1.99%.
As of 2026-07-30, Johnson & Johnson(JNJ) stock has fluctuated between $254.56 and $261.00. The current price stands at $256.22, placing the stock +0.7% above today's low and -1.8% off the high.
The Johnson & Johnson(JNJ)'s current trading volume is 8.22M, compared to an average daily volume of 8.69M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $274.90 and a 52-week low of $164.23.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $274.90 and a 52-week low of $164.23.
JNJ News
Cash, cash equivalents and marketable securities were $236.6 million as of June 30, 2026. Contineum (CTNM) believes its cash resources are sufficient to fund it...
...
Johnson & Johnson announced that the FDA has granted Priority Review to the supplemental Biologics License Application for Rybrevant Faspro, or subcutaneous ami...
Analyst ratings
73%
of 26 ratingsMore JNJ News
Johnson & Johnson will also make an equity investment in Sail. Kyle Grillot / Bloomberg News Johnson & Johnson JNJ -0.45 %decrease; down pointing triangle said...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Johnson & Johnson “announced strategic agreements and collaboration with Sail Biomedicines (Sail), a biotechnology company developing in vivo CAR-T therapies fo...
Key Points Revolution Medicines has a promising cancer drug in development. Even with this medicine's prospects, the stock's valuation looks too frothy. 10 s...
Argus analyst David Toung raised the firm’s price target on Johnson & Johnson to $300 from $290 and keeps a Buy rating on the shares. The firm is citing the com...
Key Points Eli Lilly currently displays stronger upward momentum in top-line growth, whereas Johnson & Johnson maintains a higher but flatter overall baseline....
Johnson & Johnson stock has delivered a 76.0% return over the past five years, while a Discounted Cash Flow (DCF) intrinsic value estimate currently points to t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.